About Us
Cardiovascular Disease - Preclinical Status
Cytori has conducted multiple preclinical studies in preparation for clinical trials. Below is a summary of the results, which show consistent improvement in heart function and a corresponding reduction in the size of heart injury.
| Consistent Improvement | |
| Chronic Ischemia | 13% Greater efficiency (ejection fraction) Less scar tissue |
| Heart Attack | 8% Greater efficiency (ejection fraction) 9% Smaller injury |
| Heart Attack | 9% Greater efficiency (ejection fraction) 7% Smaller injury |
| Heart Attack | 12% Greater Efficiency (ejection fraction) |
Cytori’s Celution™ System is not available for sale in the United States or for patient use in Japan. This website is not intended to provide medical advice or as a substitute for professional healthcare. Consult your doctor or medical provider for information about your diagnosis, treatment or condition.